Cargando…
Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition
BACKGROUND AND AIM: Fluoropyrimidines (FPs) are key drugs in many chemotherapy regimens; however, recipients are often prone to diarrhea due to gastrointestinal toxicity. Disruption of the intestinal epithelial barrier function by FPs leads to dysbiosis, which may exacerbate intestinal epithelial ce...
Autores principales: | Kawasaki, Yuka, Kakimoto, Kazuki, Tanaka, Yasuyoshi, Shimizu, Hikaru, Nishida, Koji, Numa, Keijiro, Kinoshita, Naohiko, Tatsumi, Yoshihiro, Nakazawa, Kei, Koshiba, Ryoji, Hirata, Yuki, Ota, Kazuhiro, Sakiyama, Naokuni, Terazawa, Tetsuji, Takeuchi, Toshihisa, Miyazaki, Takako, Goto, Masahiro, Yokota, Haruka, Makizaki, Yutaka, Tanaka, Yoshiki, Nakajima, Shunji, Ohno, Hiroshi, Higuchi, Kazuhide, Nakamura, Shiro, Nishikawa, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614279/ https://www.ncbi.nlm.nih.gov/pubmed/37231829 http://dx.doi.org/10.1159/000528282 |
Ejemplares similares
-
Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022) -
Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023) -
Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022) -
Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis
por: Tawa, Hideki, et al.
Publicado: (2022) -
Fr581 EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
por: Hirata, Yuki, et al.
Publicado: (2021)